Neion Bio Closes $23M Series A to Scale Biologics Manufacturing
The oversubscribed round signals continued investor appetite for vertically integrated, U.S.-based biologics infrastruc…
The oversubscribed round signals continued investor appetite for vertically integrated, U.S.-based biologics infrastruc…
Portfolio now exceeds 100 active granted patents and applications globally, reinforcing IP barriers in the competitive …
Quetzal Therapeutics' oral delivery format targets a key bioavailability challenge for a proven IV-administered oncolog…
The research-grade launch signals growing supplier investment in documentation standards as peptide ingredient scrutiny…
The GPCR-targeting therapeutic protein enters mid-stage evaluation in a severe cardiopulmonary subpopulation — but this…
The program is positioned strictly for research use, keeping it outside finished-formulation and dietary supplement cha…
The prescription re-entry addresses a documented gap in pediatric ophthalmic allergy care, though the product falls out…
Cellectis' experimental allogeneic CAR-T therapy lasme-cel receives FDA fast-track designation for treating patients wi…
Cellectis's allogeneic CAR-T therapy lasmé-cel receives FDA advanced therapy status for treating relapsed or refractory…
UFC Champion Alex Pereira launches Chama, a premium nutraceutical brand, coinciding with his White House title fight bi…
iMDx will showcase its GraftAssure transplant testing technology at the American Transplant Congress in Boston next wee…
The ROOT Brands and Dr. Christina Rahm received two Gold Stevie Awards recognizing innovation and manufacturing excelle…